Stay updated on Talazoparib in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talazoparib in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added and Revision: v3.6.1 was removed, indicating a version update to the page or its underlying system.
    Difference
    0.0%
    Check dated 2026-07-09T09:08:54.000Z thumbnail image
  2. Check
    18 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.1, replacing the previous v3.6.0 in the study documents section.
    Difference
    0.0%
    Check dated 2026-06-25T06:51:49.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    A recruitment status update 'No longer looking for participants' was added, indicating that enrollment for the EMBRACA study is closed. New navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and a revision tag update to v3.6.0 were introduced, while the Interventions/Treatment heading formatting was adjusted.
    Difference
    0.1%
    Check dated 2026-06-18T05:32:30.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The revision history now shows v3.5.5, replacing the previous v3.5.4 and indicating a minor update to the page's version history.
    Difference
    0.0%
    Check dated 2026-06-03T23:00:52.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a new revision label (v3.5.4) replacing the previous v3.5.3, indicating a backend/template update rather than changes to the study information.
    Difference
    0.0%
    Check dated 2026-05-20T15:15:00.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3 in the footer, replacing the previous Revision: v3.5.2. This indicates a software update to the page rather than a change to study details or content.
    Difference
    0.0%
    Check dated 2026-04-29T08:57:11.000Z thumbnail image

Stay in the know with updates to Talazoparib in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib in BRCA+ Breast Cancer Clinical Trial page.